David Larsen
Stock Analyst at BTIG
(1.87)
# 3,239
Out of 5,146 analysts
102
Total ratings
33.33%
Success rate
-7.16%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HIMS Hims & Hers Health | Downgrades: Neutral | n/a | $15.46 | - | 4 | Feb 24, 2026 | |
| HQY HealthEquity | Maintains: Buy | $130 → $110 | $75.89 | +44.95% | 6 | Feb 17, 2026 | |
| CCSI Consensus Cloud Solutions | Maintains: Buy | $37 → $40 | $30.15 | +32.67% | 4 | Feb 17, 2026 | |
| DOCS Doximity | Maintains: Buy | $80 → $50 | $24.07 | +107.73% | 3 | Feb 6, 2026 | |
| LFST LifeStance Health Group | Maintains: Buy | $10 → $11 | $7.14 | +54.06% | 3 | Feb 2, 2026 | |
| BTSG BrightSpring Health Services | Maintains: Buy | $50 → $55 | $40.30 | +36.48% | 5 | Feb 2, 2026 | |
| ASTH Astrana Health | Maintains: Buy | $45 → $40 | $19.22 | +108.12% | 3 | Feb 2, 2026 | |
| EVH Evolent Health | Maintains: Buy | $16 → $10 | $2.56 | +290.63% | 8 | Feb 2, 2026 | |
| MDLN Medline | Initiates: Buy | $50 | $49.99 | +0.02% | 1 | Jan 12, 2026 | |
| SLP Simulations Plus | Downgrades: Neutral | n/a | $11.59 | - | 4 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Suspends: Neutral | n/a | $2.15 | - | 3 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Suspends: Neutral | n/a | $0.39 | - | 2 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $340 | $175.79 | +93.41% | 4 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $10 | $2.67 | +274.53% | 4 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.58 | +171.32% | 1 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $15 | $8.27 | +81.38% | 4 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.73 | - | 4 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 | $20.78 | +34.74% | 4 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $290 → $260 | $164.88 | +57.69% | 2 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $1.39 | +403.60% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $7 | $0.74 | +843.27% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $40.15 | - | 7 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $21.53 | +62.56% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.54 | - | 3 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $5.42 | - | 1 | Jan 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $225.97 | - | 6 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $170 → $160 | $957.36 | -83.29% | 2 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $83.35 | - | 5 | Apr 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $74.18 | +14.59% | 3 | Feb 9, 2018 |
Hims & Hers Health
Feb 24, 2026
Downgrades: Neutral
Price Target: n/a
Current: $15.46
Upside: -
HealthEquity
Feb 17, 2026
Maintains: Buy
Price Target: $130 → $110
Current: $75.89
Upside: +44.95%
Consensus Cloud Solutions
Feb 17, 2026
Maintains: Buy
Price Target: $37 → $40
Current: $30.15
Upside: +32.67%
Doximity
Feb 6, 2026
Maintains: Buy
Price Target: $80 → $50
Current: $24.07
Upside: +107.73%
LifeStance Health Group
Feb 2, 2026
Maintains: Buy
Price Target: $10 → $11
Current: $7.14
Upside: +54.06%
BrightSpring Health Services
Feb 2, 2026
Maintains: Buy
Price Target: $50 → $55
Current: $40.30
Upside: +36.48%
Astrana Health
Feb 2, 2026
Maintains: Buy
Price Target: $45 → $40
Current: $19.22
Upside: +108.12%
Evolent Health
Feb 2, 2026
Maintains: Buy
Price Target: $16 → $10
Current: $2.56
Upside: +290.63%
Medline
Jan 12, 2026
Initiates: Buy
Price Target: $50
Current: $49.99
Upside: +0.02%
Simulations Plus
Dec 18, 2025
Downgrades: Neutral
Price Target: n/a
Current: $11.59
Upside: -
Dec 12, 2025
Suspends: Neutral
Price Target: n/a
Current: $2.15
Upside: -
Dec 12, 2025
Suspends: Neutral
Price Target: n/a
Current: $0.39
Upside: -
Nov 21, 2025
Reiterates: Buy
Price Target: $340
Current: $175.79
Upside: +93.41%
Nov 18, 2025
Maintains: Buy
Price Target: $18 → $10
Current: $2.67
Upside: +274.53%
Oct 21, 2025
Reiterates: Buy
Price Target: $7
Current: $2.58
Upside: +171.32%
Sep 18, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $8.27
Upside: +81.38%
Sep 5, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.73
Upside: -
Mar 31, 2025
Upgrades: Buy
Price Target: $28
Current: $20.78
Upside: +34.74%
Nov 1, 2024
Maintains: Buy
Price Target: $290 → $260
Current: $164.88
Upside: +57.69%
Sep 17, 2024
Initiates: Buy
Price Target: $7
Current: $1.39
Upside: +403.60%
May 9, 2024
Maintains: Buy
Price Target: $11 → $7
Current: $0.74
Upside: +843.27%
Nov 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $40.15
Upside: -
Apr 28, 2022
Initiates: Buy
Price Target: $35
Current: $21.53
Upside: +62.56%
Nov 22, 2021
Downgrades: Neutral
Price Target: n/a
Current: $4.54
Upside: -
Jan 7, 2021
Initiates: Neutral
Price Target: n/a
Current: $5.42
Upside: -
Nov 16, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $225.97
Upside: -
May 29, 2018
Maintains: Market Perform
Price Target: $170 → $160
Current: $957.36
Upside: -83.29%
Apr 4, 2018
Upgrades: Outperform
Price Target: n/a
Current: $83.35
Upside: -
Feb 9, 2018
Maintains: Outperform
Price Target: $90 → $85
Current: $74.18
Upside: +14.59%